Essential Thrombocythemia (ET) is a rare blood disorder where bone marrow produces too many platelets, increasing the risk of blood clots or bleeding. It is caused by genetic mutations, most commonly the JAK2 V617F mutation, which abnormally activates cellular signaling pathways controlling blood cell proliferation. The JAK2 V617F Mutation Analysis is the most important test for diagnosis, as it identifies this mutation in 50-60% of ET patients.
90-day money-back guarantee
Lab order in minutes
Save a trip to the doctor
Low prices since 2005
Labs within 2 miles
Essential Thrombocythemia is caused by genetic mutations that disrupt normal blood cell production in the bone marrow. The JAK2 V617F mutation accounts for 50-60% of cases, while CALR and MPL gene mutations cause most remaining cases. These mutations lead to abnormal activation of signaling pathways that control platelet production, resulting in bone marrow creating far too many platelets that can increase your risk of dangerous blood clots or unexpected bleeding episodes.
The JAK2 V617F Mutation Analysis is the most important test for Essential Thrombocythemia because it detects the specific genetic mutation responsible for 50-60% of cases. This blood test analyzes your DNA to identify the JAK2 V617F mutation that causes abnormal activation of cellular signaling pathways controlling platelet production. When combined with a complete blood count showing persistently elevated platelet levels (typically above 450,000 per microliter), a positive JAK2 mutation strongly confirms the diagnosis. If the JAK2 test is negative, your doctor may order additional genetic testing for CALR or MPL mutations, which account for most other ET cases.
You should get tested if routine blood work shows your platelet count is consistently elevated above 450,000 per microliter, especially if you have unexplained symptoms like headaches, dizziness, chest pain, or vision changes. Testing is also important if you have experienced unexplained blood clots, excessive bruising, or unusual bleeding episodes. Additionally, if you have a family history of blood disorders or if your doctor noticed an enlarged spleen during a physical exam, genetic testing can help determine if Essential Thrombocythemia is the underlying cause of these abnormalities.
Save a trip to the doctor, go directly to the lab
Instant orders, results often overnight*
Results explained in simple language
Reviewed by US licensed doctors
Fast & confidential, we never sell or share your data
No insurance needed, transparent pricing
What this means
Your test came back negative, meaning the JAK2 V617F mutation was not detected in your blood sample. This is the expected result for most people and may help rule out certain myeloproliferative disorders, though your doctor may recommend additional testing if symptoms persist.
Recommended actions
Continue monitoring your blood counts with regular check-ups as recommended by your doctor
Discuss any persistent symptoms like fatigue, headaches, or unusual blood work findings with your healthcare provider
Consider additional genetic testing if your doctor suspects other mutations may be present
Maintain healthy lifestyle habits including regular exercise and a balanced diet to support overall blood health
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
3303 reviews
Sample results
Your 24/7 Personal Lab Guide
Quick questions:
